Bibliographic Details
| Title: |
Case report: ocular manifestations of a gain-of-function mutation in CLCN6, a newly diagnosed disease. |
| Authors: |
Kimera, Lawrencia1 (AUTHOR), Nadimpalli, Sameera2 (AUTHOR), Kurup, Sudhi2,3 (AUTHOR), Cole, F. Sessions4,5 (AUTHOR), Huang, Russell3 (AUTHOR), Sisco, Kathleen6 (AUTHOR), Ranaivo, Hantamalala Ranay2 (AUTHOR), Shinawi, Marwan6 (AUTHOR), Dickson, Patricia6 (AUTHOR), Mian, Ali7 (AUTHOR), Reynolds, Margaret1 (AUTHOR) margaret.reynolds@wustl.edu, Undiagnosed Diseases Network (AUTHOR) |
| Source: |
Ophthalmic Genetics. Jun2024, Vol. 45 Issue 3, p271-274. 4p. |
| Subject Terms: |
*MEMBRANE transport proteins, *CHLORIDE channels, *GAIN-of-function mutations, *ION transport (Biology), *OPTIC nerve |
| Abstract: |
In 2020, a new disease was reported by Polovitskaya et al., caused by a monoallelic, gain-of-function mutation in CLCN6, encoding the ClC-6 Cl−/H±exchanger. Here, we report the ophthalmic findings of one of the first three patients with this disease (the proband) and review the findings in the other two patients in the literature. The CLCN6 gene is part of the voltage-dependent chloride channel protein family. It functions as either a chloride channel aiding in cell-volume regulation and acidification of intracellular organelles or as an antiporter, which are membrane proteins involved in the transport of molecules across a phospholipid membrane. This particular gene is found in late endosomes. Ion transport across endosome membranes is essential for endosomal function. The proband carried a de novo c.1658A>G (p.Tyr553Cys) mutation in CLCN6. The patient reported herein has a notable optic nerve appearance. The nerve initially appeared elevated. Over time, the optic nerve elevation appearance decreased, associated with progressive vision loss with a visual acuity of 20/470 at last follow-up. While Clcn6−/− mice have been found to have a mild neuronal lysosomal storage phenotype, the three reported children with a de novo c.1658A>G (p.Tyr553Cys) variant displayed significant developmental delay and neurodegeneration. [ABSTRACT FROM AUTHOR] |
|
Copyright of Ophthalmic Genetics is the property of Taylor & Francis Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
